Improved brimonidine compositions for treating erythema

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/498 (2006.01) A61P 17/00 (2006.01)

Patent

CA 2698680

The present invention is directed to a pharmaceutical composition including brimonidine tartrate in an amount from about 0.17 percent by weight to about 0.19 percent by weight in a pharmaceutically acceptable carrier such as a gel or cream. The invention also relates to a method and/or use of treating erythema in a patient with rosacea by administering the composition of the invention to the site of erythema on the skin of the patient.

La présente invention concerne une composition pharmaceutique comprenant du tartrate de brimonidine, entre environ 0,17 pour cent en poids et environ 0,19 pour cent en poids dans un vecteur pharmaceutiquement acceptable comme un gel ou une crème. L'invention concerne également un procédé ou une utilisation du traitement de l'érythème chez un patient ayant une acné rosacée en administrant la composition de l'invention sur le site de l'érythème sur la peau du patient.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Improved brimonidine compositions for treating erythema does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improved brimonidine compositions for treating erythema, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved brimonidine compositions for treating erythema will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1659321

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.